Compare TRN & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRN | HTFL |
|---|---|---|
| Founded | 1933 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2025 |
| Metric | TRN | HTFL |
|---|---|---|
| Price | $28.50 | $30.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $28.00 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 901.6K | 832.3K |
| Earning Date | 02-12-2026 | 03-27-2026 |
| Dividend Yield | ★ 4.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $2,175,100,000.00 | $161,881,000.00 |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $3.66 | $22.27 |
| P/E Ratio | $24.73 | ★ N/A |
| Revenue Growth | N/A | ★ 85.70 |
| 52 Week Low | $22.38 | $25.38 |
| 52 Week High | $38.80 | $41.22 |
| Indicator | TRN | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 46.06 |
| Support Level | $26.99 | $30.33 |
| Resistance Level | $27.71 | $32.75 |
| Average True Range (ATR) | 0.72 | 2.05 |
| MACD | 0.05 | -0.43 |
| Stochastic Oscillator | 64.13 | 10.27 |
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.